Role of B:T cell ratio in suppression of clinical signs: a model for silent MS

about

Role of B:T cell ratio in suppression of clinical signs: a model for silent MS

Item

http://www.wikidata.org/entity/Q37037819

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 08 April 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Role of B:T cell ratio in suppression of clinical signs: a model for silent MS

@en

Role of B:T cell ratio in suppression of clinical signs: a model for silent MS.

@nl

type

Item

label

Role of B:T cell ratio in suppression of clinical signs: a model for silent MS

@en

Role of B:T cell ratio in suppression of clinical signs: a model for silent MS.

@nl

prefLabel

Role of B:T cell ratio in suppression of clinical signs: a model for silent MS

@en

Role of B:T cell ratio in suppression of clinical signs: a model for silent MS.

@nl

P1476

Role of B:T cell ratio in suppression of clinical signs: a model for silent MS

@en

P2093

Jane E Libbey

http://www.w3.org/2001/XMLSchema#string

Lisa K Peterson

http://www.w3.org/2001/XMLSchema#string

Robert S Fujinami

http://www.w3.org/2001/XMLSchema#string

P2860

Defining the clinical course of multiple sclerosis: Results of an international survey

A clinical patho-anatomical study of clinically silent multiple sclerosis

Molecular characterization of antibody specificities against myelin/oligodendrocyte glycoprotein in autoimmune demyelination

Lymphoid neogenesis: de novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines.

Oligodendrocyte and axon pathology in clinically silent multiple sclerosis lesions.

The spectrum of multiple sclerosis and treatment decisions.

Cytokines in the pathogenesis and therapy of autoimmune encephalomyelitis and multiple sclerosis.

Axonal injury heralds virus-induced demyelination.

Acute autoimmune encephalomyelitis in mice. II. Susceptibility is controlled by the combination of H-2 and histamine sensitization genes

IL-12 unmasks latent autoimmune disease in resistant mice.

P304

28-39

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.YEXMP.2008.03.005

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ikuo Tsunoda

P577

2008-04-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5363433

http://www.w3.org/2001/XMLSchema#string

P698

18486939

http://www.w3.org/2001/XMLSchema#string

P932

2614211

http://www.w3.org/2001/XMLSchema#string